共 90 条
[8]
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
[J].
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2017, 76 (03)
:405-417
[9]
Role of immune cells in hypertension
[J].
BRITISH JOURNAL OF PHARMACOLOGY,
2019, 176 (12)
:1818-1828